Methodological vexation about thiol oxidation versus S-nitrosation-A commentary on "An ascorbate-dependent artifact that interferes with the interpretation of the biotin-switch assay"

Free Radical Biology and Medicine

Volumn 41, Issue 4, 2006, Pages 557-561

  Gladwin, Mark T ^a,b   Wang, Xunde ^a,b   Hogg, Neil ^c  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c FREE RADICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BIOTIN; CYSTEINE; ENZYME; GLUTAREDOXIN; N ETHYLMALEIMIDE; PEROXIREDOXIN; SMALL INTERFERING RNA; SULFENIC ACID DERIVATIVE; SULFINIC ACID DERIVATIVE; SULFIREDOXIN; SULFONIC ACID DERIVATIVE; THIOL; THIOMESYLIC ACID METHYL ESTER; UNCLASSIFIED DRUG;

ARTICLE; BIOTINYLATION; CHEMOLUMINESCENCE; LIPID OXIDATION; NITROSATION; NITROSYLATION; OXIDATION; OXIDATION REDUCTION REACTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPIN TRAPPING;

EID: 33746085196     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.05.025     Document Type: Note

References (58)

1. Biswas S., Chida A.S., and Rahman I. Redox modifications of protein-thiols: emerging roles in cell signaling. Biochem. Pharmacol. 71 (2006) 551-564
2. Foster M.W., McMahon T.J., and Stamler J.S. S-Nitrosylation in health and disease. Trends Mol. Med. 9 (2003) 160-168
3. Levonen A.L., Landar A., Ramachandran A., Ceaser E.K., Dickinson D.A., Zanoni G., Morrow J.D., and Darley-Usmar V.M. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 378 (2004) 373-382
4. Georgiou G., and Masip L. Biochemistry. An overoxidation journey with a return ticket. Science 300 (2003) 592-594
5. Biteau B., Labarre J., and Toledano M.B. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425 (2003) 980-984
6. Rhee S.G., Chae H.Z., and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38 (2005) 1543-1552
7. Woo H.A., Chae H.Z., Hwang S.C., Yang K.S., Kang S.W., Kim K., and Rhee S.G. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300 (2003) 653-656
8. Kim S.O., Merchant K., Nudelman R., Beyer Jr. W.F., Keng T., DeAngelo J., Hausladen A., and Stamler J.S. OxyR: a molecular code for redox-related signaling. Cell 109 (2002) 383-396
9. Konorev E.A., Kalyanaraman B., and Hogg N. Modification of creatine kinase by S-nitrosothiols: S-nitrosation vs. S- thiolation. Free Radic. Biol. Med. 28 (2000) 1671-1678
10. Adachi T., Weisbrod R.M., Pimentel D.R., Ying J., Sharov V.S., Schoneich C., and Cohen R.A. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat. Med. 10 (2004) 1200-1207
11. Zheng M., Aslund F., and Storz G. Activation of the OxyR transcription factor by reversible disulfide bond formation. Science 279 (1998) 1718-1721
12. Gladwin M.T., Wang X., Reiter C.D., Yang B.K., Vivas E.X., Bonaventura C., and Schechter A.N. S-Nitrosohemoglobin is unstable in the reductive red cell environment and lacks O2/NO-linked allosteric function. J. Biol. Chem. 21 (2002) 27818-27828
13. Stamler J.S., Jaraki O., Osborne J., Simon D.I., Keaney J., Vita J., Singel D., Valeri C.R., and Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA 89 (1992) 7674-7677
14. Rossi R., Giustarini D., Milzani A., Colombo R., Dalle-Donne I., and Di Simplicio P. Physiological levels of S-nitrosothiols in human plasma. Circ. Res. 89 (2001) E47
15. Rassaf T., Preik M., Kleinbongard P., Lauer T., Heiss C., Strauer B.E., Feelisch M., and Kelm M. Evidence for in vivo transport of bioactive nitric oxide in human plasma. J. Clin. Invest. 109 (2002) 1241-1248
16. Rassaf T., Bryan N.S., Kelm M., and Feelisch M. Concomitant presence of N-nitroso and S-nitroso proteins in human plasma. Free Radic. Biol. Med. 33 (2002) 1590-1596
17. Marley R., Feelisch M., Holt S., and Moore K. A chemiluminescense-based assay for S-nitrosoalbumin and other plasma S- nitrosothiols. Free Radic. Res. 32 (2000) 1-9
18. Marley R., Patel R.P., Orie N., Ceaser E., Darley-Usmar V., and Moore K. Formation of nanomolar concentrations of S-nitroso-albumin in human plasma by nitric oxide. Free Radic. Biol. Med. 31 (2001) 688-696
19. Jourd'heuil D., Hallen K., Feelisch M., and Grisham M.B. Dynamic state of S-nitrosothiols in human plasma and whole blood. Free Radic. Biol. Med. 28 (2000) 409-417
20. Gladwin M.T., Ognibene F.P., Pannell L.K., Nichols J.S., Pease-Fye M.E., Shelhamer J.H., and Schechter A.N. Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation. [In Process Citation]. Proc. Natl. Acad. Sci. USA 97 (2000) 9943-9948
21. Baker P.R., Lin Y., Schopfer F.J., Woodcock S.R., Groeger A.L., Batthyany C., Sweeney S., Long M.H., Iles K.E., Baker L.M., Branchaud B.P., Chen Y.E., and Freeman B.A. Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. J. Biol. Chem. 280 (2005) 42464-42475
22. Wang X., Tanus-Santos J.E., Reiter C.D., Dejam A., Shiva S., Smith R.D., Hogg N., and Gladwin M.T. Biological activity of nitric oxide in the plasmatic compartment. Proc. Natl. Acad. Sci. USA 101 (2004) 11477-11482
23. McMahon T.J., Moon R.E., Luschinger B.P., Carraway M.S., Stone A.E., Stolp B.W., Gow A.J., Pawloski J.R., Watke P., Singel D.J., Piantadosi C.A., and Stamler J.S. Nitric oxide in the human respiratory cycle. Nat. Med. 3 (2002) 711-717
24. Tyurin V.A., Liu S.X., Tyurina Y.Y., Sussman N.B., Hubel C.A., Roberts J.M., Taylor R.N., and Kagan V.E. Elevated levels of S-nitrosoalbumin in preeclampsia plasma. Circ. Res. 88 (2001) 1210-1215
25. Dejam A., Kleinbongard P., Rassaf T., Hamada S., Gharini P., Rodriguez J., Feelisch M., and Kelm M. Thiols enhance NO formation from nitrate photolysis. Free Radic. Biol. Med. 35 (2003) 1551-1559
26. Jaffrey S.R., Erdjument-Bromage H., Ferris C.D., Tempst P., and Snyder S.H. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol. 3 (2001) 193-197
27. Gandley R.E., Tyurin V.A., Huang W., Arroyo A., Daftary A., Harger G., Jiang J., Pitt B., Taylor R.N., Hubel C.A., and Kagan V.E. S-nitrosoalbumin-mediated relaxation is enhanced by ascorbate and copper: effects in pregnancy and preeclampsia plasma. Hypertension 45 (2005) 21-27
28. Huang; Chen. An ascorbate-dependent artifact that interferes with the interpretation of the biotin-switch assay. Free Radic. Biol. Med. doi:10.1016/j.freeradbiomed.2006.03.006.
29. Landino L.M., Koumas M.T., Mason C.E., and Alston J.A. Ascorbic acid reduction of microtubule protein disulfides and its relevance to protein S-nitrosylation assays. Biochem. Biophys. Res. Commun. 340 (2006) 347-352
30. Hara M.R., Agrawal N., Kim S.F., Cascio M.B., Fujimuro M., Ozeki Y., Takahashi M., Cheah J.H., Tankou S.K., Hester L.D., Ferris C.D., Hayward S.D., Snyder S.H., and Sawa A. S-Nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat. Cell Biol. 7 (2005) 665-674
31. Zhang Y., Keszler A., Broniowska K.A., and Hogg N. Characterization and application of the biotin-switch assay for the identification of S-nitrosated proteins. Free Radic. Biol. Med. 38 (2005) 874-881
32. Yang B.K., Vivas E.X., Reiter C.D., and Gladwin M.T. Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic. Res. 37 (2003) 1-10
33. Feelisch M., Rassaf T., Mnaimneh S., Singh N., Bryan N.S., Jourd'Heuil D., and Kelm M. Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo. FASEB J. 16 (2002) 1775-1785
34. Burwell L.S., Nadtochiy S.M., Tompkins A.J., Young S., and Brookes P.S. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem. J. 394 (2006) 627-634
35. Datta B., Tufnell-Barrett T., Bleasdale R.A., Jones C.J., Beeton I., Paul V., Frenneaux M., and James P. Red blood cell nitric oxide as an endocrine vasoregulator: a potential role in congestive heart failure. Circulation 109 (2004) 1339-1342
36. MacMicking J.D., North R.J., LaCourse R., Mudgett J.S., Shah S.K., and Nathan C.F. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94 (1997) 5243-5248
37. Minamiyama Y., Takemura S., and Inoue M. Albumin is an important vascular tonus regulator as a reservoir of nitric oxide. Biochem. Biophys. Res. Commun. 225 (1996) 112-115
38. Napoli C., Aldini G., Wallace J.L., de Nigris F., Maffei R., Abete P., Bonaduce D., Condorelli G., Rengo F., Sica V., D'Armiento F.P., Mignogna C., de Rosa G., Condorelli M., Lerman L.O., and Ignarro L.J. Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis. Proc. Natl. Acad. Sci. USA 99 (2002) 1689-1694
39. Massy Z.A., Fumeron C., Borderie D., Tuppin P., Nguyen-Khoa T., Benoit M.O., Jacquot C., Buisson C., Drueke T.B., Ekindjian O.G., Lacour B., and Iliou M.C. Increased pasma S-nitrosothiol concentrations predict cardiovascular outcomes among patients with end-stage renal disease: a prospective study. J. Am. Soc. Nephrol. 15 (2004) 470-476
40. Fang K., Ragsdale N.V., Carey R.M., MacDonald T., and Gaston B. Reductive assays for S-nitrosothiols: implications for measurements in biological systems. Biochem. Biophys. Res. Commun. 252 (1998) 535-540
41. Keaney Jr. J.F., Simon D.I., Stamler J.S., Jaraki O., Scharfstein J., Vita J.A., and Loscalzo J. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J. Clin. Invest. 91 (1993) 1582-1589
42. Marzinzig M., Nussler A.K., Stadler J., Marzinzig E., Barthlen W., Nussler N.C., Beger H.G., Morris Jr. S.M., and Bruckner U.B. Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide 1 (1997) 177-189
43. Massy Z.A., Borderie D., Nguyen-Khoa T., Drueke T.B., Ekindjian O.G., and Lacour B. Increased plasma S-nitrosothiol levels in chronic haemodialysis patients. Nephrol. Dial. Transplant. 18 (2003) 153-157
44. Ewing J.F., and Janero D.R. Specific S-nitrosothiol (thionitrite) quantification as solution nitrite after vanadium(III) reduction and ozone-chemiluminescent detection. Free Radic. Biol. Med. 25 (1998) 621-628
45. Moriel P., Pereira I.R., Bertolami M.C., and Abdalla D.S. Is ceruloplasmin an important catalyst for S-nitrosothiol generation in hypercholesterolemia?. Free Radic. Biol. Med. 30 (2001) 318-326
46. Scharfstein J.S., Keaney Jr. J.F., Slivka A., Welch G.N., Vita J.A., Stamler J.S., and Loscalzo J. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J. Clin. Invest. 94 (1994) 1432-1439
47. Goldman R.K., Vlessis A.A., and Trunkey D.D. Nitrosothiol quantification in human plasma. Anal. Biochem. 259 (1998) 98-103
48. Ottesen L.H., Harry D., Frost M., Davies S., Khan K., Halliwell B., and Moore K. Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia. Free Radic. Biol. Med. 31 (2001) 790-798
49. Tsikas D., Sandmann J., Gutzki F.M., Stichtenoth D.O., and Frolich J.C. Measurement of S-nitrosoalbumin by gas chromatography-mass spectrometry: II. Quantitative determination of S-nitrosoalbumin in human plasma using S-[15N]nitrosoalbumin as internal standard. J. Chromatogr. B: Biomed. Sci. Appl. 726 (1999) 13-24
50. Tsikas D., Sandmann J., Rossa S., Gutzki F.M., and Frolich J.C. Measurement of S-nitrosoalbumin by gas chromatography-mass spectrometry. I. Preparation, purification, isolation, characterization and metabolism of S-[15N]nitrosoalbumin in human blood in vitro. J. Chromatogr. B: Biomed. Sci. Appl. 726 (1999) 1-12
51. Jourd'heuil D., Gray L., and Grisham M.B. S-Nitrosothiol formation in blood of lipopolysaccharide-treated rats. Biochem. Biophys. Res. Commun. 273 (2000) 22-26
52. Gladwin M.T., Shelhamer J.H., Schechter A.N., Pease-Fye M.E., Waclawiw M.A., Panza J.A., Ognibene F.P., and Cannon III R.O. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc. Natl. Acad. Sci. USA 97 (2000) 11482-11487
53. Cannon III R.O., Schechter A.N., Panza J.A., Ognibene F.P., Pease-Fye M.E., Waclawiw M.A., Shelhamer J.H., and Gladwin M.T. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J. Clin. Invest. 108 (2001) 279-287
54. Rassaf T., Kleinbongard P., Preik M., Dejam A., Gharini P., Lauer T., Erckenbrecht J., Duschin A., Schulz R., Heusch G., Feelisch M., and Kelm M. Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: experimental and clinical study on the fate of NO in human blood. Circ. Res. 91 (2002) 470-477
55. Reiter C.D., Wang X., Tanus-Santos J.E., Hogg N., Cannon R.O., Schechter A.N., and Gladwin M.T. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8 (2002) 1383-1389
56. Bryan N.S., Rassaf T., Maloney R.E., Rodriguez C.M., Saijo F., Rodriguez J.R., and Feelisch M. Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc. Natl. Acad. Sci. USA 101 12 (2004) 4308-4313
57. Ng E.S., Jourd'heuil D., McCord J.M., Hernandez D., Yasui M., Knight D., and Kubes P. Enhanced S-nitroso-albumin formation from inhaled NO during ischemia/reperfusion. Circ. Res. 94 (2004) 559-565
58. Rocks S.A., Davies C.A., Hicks S.L., Webb A.J., Klocke R., Timmins G.S., Johnston A., Jawad A.S., Blake D.R., Benjamin N., and Winyard P.G. Measurement of S-nitrosothiols in extracellular fluids from healthy human volunteers and rheumatoid arthritis patients, using electron paramagnetic resonance spectrometry. Free Radic. Biol. Med. 39 (2005) 937-948